Cerebrolysin

As research shows

Cerebrolysin is a multicomponent peptide preparation derived from porcine brain tissue, containing biologically active neuropeptides and amino acids with molecular weights below 10 kDa. This low molecular weight allows it to cross the blood–brain barrier and exert neurotrophic effects similar to endogenous factors like nerve growth factor (NGF) and brain‑derived neurotrophic factor (BDNF). Preclinical studies demonstrate neuroprotective effects including reduced infarct size and improved recovery in ischemia models. Human trials have examined its use in stroke, dementia, and traumatic brain injury with mixed but generally favorable tolerability profiles.

Key benefits

• Preclinical models consistently show neuroprotective effects including reduced neuronal damage and improved functional recovery after ischemic insult.
• Meta‑analyses of human dementia trials suggest modest cognitive benefits with daily IV infusions; stroke trial results have been more variable